WORLD
The advice is another setback for the drug, which grabbed worldwide attention as a potentially effective treatment for COVID-19 in the summer after early trials showed some promise.
Gilead's drug remdesivir is not recommended for patients hospitalised with COVID-19, regardless of how ill they are, as there is no evidence it improves survival or reduces the need for ventilation, a World Health Organization panel said on Friday.
"The ... panel found a lack of evidence that remdesivir improved outcomes that matter to patients such as reduced mortality, need for mechanical ventilation, time to clinical improvement, and others," the guideline said.
The advice is another setback for the drug, which grabbed worldwide attention as a potentially effective treatment for COVID-19 in the summer after early trials showed some promise.
At the end of October, Gilead cut its 2020 revenue forecast, citing lower-than-expected demand and difficulty in predicting sales of remdesivir.
The antiviral is one of only two medicines currently authorised to treat COVID-19 patients across the world, but a large WHO-led trial known as the Solidarity Trial showed last month that it had little or no effect on 28-day mortality or length of hospital stays for COVID-19 patients.
The medication was one of the drugs used to treat U.S. President Donald Trump's coronavirus infection, and had been shown in previous studies to have cut time to recovery. It is authorised or approved for use as a COVID-19 treatment in more than 50 countries.
Gilead has questioned the Solidarity Trial's results.
The WHO's Guideline Development Group (GDG) panel said its recommendation was based on an evidence review that included data from four international randomised trials involving more than 7,000 patients hospitalised with COVID-19.
After reviewing the evidence, the panel said, it concluded that remdesivir, which has to be given intravenously and is therefore costly and complex to administer, has no meaningful effect on death rates or other important outcomes for patients.
"Especially given the costs and resource implications associated with remdesivir ...the panel felt the responsibility should be on demonstrating evidence of efficacy, which is not established by the currently available data," it added.
The latest WHO advice comes after one of the world's top bodies representing intensive care doctors said the antiviral should not be used for COVID-19 patients in critical care wards.
The WHO's recommendation, which is not binding, is part of its so-called "living guidelines" project, designed to offer guidance for doctors to help them make clinical decisions about patients in fast-moving situations such as the COVID-19 pandemic. The guidelines can be updated and reviewed as new evidence and information emerges.
The panel said, however, that it supported continued enrolment into clinical trials evaluating remdesivir in patients with COVID-19, which it said should "provide higher certainty of evidence for specific groups of patients".
The recommendation may raise further questions about whether the European Union will need the 500,000 courses of the antiviral worth 1 billion euros it ordered last month.
'Vibe hai': Indonesian siblings 'Dilbar' rendition leaves Big Boss fame amazed
IND vs NZ test: Recap of BGT? Rishabh Pant last hope as India close to whitewash at home after...
Warch: Land Rover bitten by Hippo, tourists witness intense faceoff as..., video goes viral
Fake IPS officer's epic dance to Bhojpuri song takes internet by storm, watch viral video
WI vs ENG: Shai Hope goes past Babar Azam, Virat Kohli in elite list with 17th ODI century
'If he doesn't resign...': Mumbai police receives threat call for UP CM Yogi Adityanath
IPL 2025: KKR CEO reveals reason that led to Shreyas Iyer's exit from franchise
HM Amit Shah releases BJP's 'Sankalp Patra' for Jharkhand assembly polls
Aishwarya Rai Bachchan recalls when she was announced Miss World 1994: 'We had rehearsals for...'
Drunk UP man call police over 250 grams missing potatoes, demands...,WATCH
Kartik Aaryan says somebody scratched him on the sets of Bhool Bhulaiyaa 3, he asks ‘if it was…’
Kiran Rao says Aamir Khan knows 'nothing' about son Azad's school: 'When we were married, I was...'
Trouble for Anil Ambani: SEBI issues demand notice of Rs 1540000000 over...
Nvidia to replace rival Intel in Dow Jones indices by November 8
Isha Ambani Vs Eiesha Bharti Pasricha: Know their net worth, college, academic qualifications
Salman Khan remembers designer Rohit Bal, says...
Bigg Boss 18: Salman Khan's Weekend Ka Vaar timing changed, details inside
Bhai Dooj 2024: Date, shubh muhurat, timings, rituals, significance
Delhi AQI touches 400: Many times over WHO limit, pollution in 'severe' category
Aishwarya Rai Bachchan says she rejected Shah Rukh Khan's film because Abhishek Bachchan wasn't...
Four children among six injured in attack on Gaza vaccination centre
IIT students launch dustbin in air using firecracker, WATCH viral video
Happy Bhai Dooj 2024: Top 50 wishes, What'sApp messages, quotes to share with your loved ones
IND vs NZ: Shubman Gill surpasses Cheteshwar Pujara in elite WTC list led by Rohit Sharma
DNA TV Show: Hindus in Bangladesh unite against fundamentalism
‘Another example of…’: MEA on Canada labelling India ‘cyber adversary’
'Bhai kyu jhooti tassali....': Mrunal Thakur criticizes fan who photoshopped her in Diwali pic
Mukesh Ambani, Anil Ambani set to earn money from Singham Again's box office collection, here’s how
Adani Power cuts Bangladesh electricity supply by half due to $846 million unpaid bills
Here's what is happening inside Ratan Tata’s Bombay House since after death of business magnate
Virat Kohli dispels retirement rumours, suggests he may continue playing cricket till....
Meet man, highest UPSC exam scorer, who broke IAS Tina Dabi's record, he is...
Swati Maliwal pours bottle of polluted water outside Delhi CM Atishi’s residence; WATCH
IPL 2025: R Ashwin tops CSK's wishlist as franchise plans to utilize RTM for THIS New Zealand star
'Abki baar...': AI imagines Donald Trump, Kamala Harris as Indian politicians, netizens react, WATCH
Amid bomb threats, ammunition cartridges found in Dubai-Delhi Air India flight
This Indian king, was first man to make history by marrying foreign woman during his trip to...
Mukesh Ambani's Jio once again TOPPED in global telecom industry, sets record in...
Bhai Dooj 2024: Date, shubh muhurat, significance, rituals and more
New ‘Satoshi Nakamoto’ emerges: Meet man who declares himself to be Bitcoin founder but fails to...
Watch: Former CSK star gets hit for 6 sixes in an over against England during Hong Kong Sixes
'Makes no sense': Ex-India star slams Rohit Sharma, Gautam Gambhir for absurd Sarfaraz Khan decision
World's richest man Elon Musk faces lawsuit from Ex-Twitter CEO Parag Agrawal for...
Security forces kill 2 terrorists, including a foreign national in Jammu and Kashmir
WWE Crown Jewel 2024: Full match card, timing, live streaming details - All you need to know
'Absurd and baseless': India dismisses Canadian minister's allegations against Amit Shah
IND vs NZ: Virat Kohli scripts history in Mumbai Test, becomes first player in world to...
This 51-year-old woman leaves husband to marry 30-year-old Indian security guard
Mukesh Ambani's best plan for Jio users, 200GB data, 90 days of unlimited calls at just Rs...
'Thanks for...': Abhishek Bachchan's viral statement amid divorce rumours with Aishwarya Rai
Jammu and Kashmir: 2 terrorists killed in encounter with security forces in Anantnag
21-Day Mars, Moon simulation in Ladakh
Prashant Kishor's fee for advising in one election will leave you shocked, it is Rs...
Dua Padukone Singh: Here's how Deepika Padukone, Ranveer Singh named their baby girl
Another BIG move by Mukesh Ambani, set to provide some help for debt-ridden Ghana as Reliance Jio...
J-K: Gun battle breaks out between security forces and terrorists in Srinagar's Khanyar